ArticleBlood cancer journal2025

Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome.

Konstantinos Soureas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.